FOXP3+ Tregs exert immunosuppressive functions in the tumor settings by restricting the development and activation of anti-tumor effector cells and facilitating the tumor immune escape (Khazaie and von Boehmer, 2006). The gene discussed is FOXP3; the disease is neoplasm.